SJOGRENS SYNDROME
Clinical trials for SJOGRENS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJOGRENS SYNDROME trials appear
Sign up with your email to follow new studies for SJOGRENS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug nipocalimab tested in 655 Sjogren's patients in major trial
Disease control OngoingThis phase 3 trial tests whether nipocalimab can safely reduce disease activity in adults with moderate to severe Sjogren's disease. About 655 participants receive either nipocalimab or a placebo, along with standard care, for 48 weeks. The main goal is to see if the drug improve…
Matched conditions: SJOGRENS SYNDROME
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Sjögren's drug ianalumab tested for Long-Term safety in 600-Patient trial
Disease control OngoingThis phase 3 study tests the long-term safety of ianalumab in 612 people with Sjögren's syndrome who already completed a year of treatment in earlier trials. Participants receive ianalumab or placebo injections for up to several more years. The goal is to see if the drug remains …
Matched conditions: SJOGRENS SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC